[1] 孙彤, 田晶, 李辰运, 等.相关实验室检查和超声特征在分化型甲状腺癌与结节性甲状腺肿鉴别诊断中的意义[J].中国超声医学杂志, 2017, 33(10):847.
[2] 田文, 郗洪庆.甲状腺癌病人生存现状分析[J].中国实用外科杂志, 2016, 36(5):489.
[3] ZHAN WW.Ultrasonic diagnosis progress of thyroid nodule[J/CD].Chin J Med Ultrasound (Electronic Edition), 2011, 8(6): 1170.
[4] PARK JY, LEE HJ, JANG HW, et al.A proposal for a thyroid imaging reporting and data system for ultrasound features of thyroid carcinoma[J].Thyroid, 2009, 19(11):1258.
[5] 刘如玉, 姜玉新, 杨筱, 等.甲状腺结节的影像报告与数据系统分级与2015年美国甲状腺学会推荐超声恶性风险分层的比较研究[J/CD].中华医学超声杂志(电子版), 2017, 14(4): 263.
[6] 林建军, 邓伟, 罗永香, 等.桥本甲状腺炎合并微小癌的超声表现与病理对照分析[J].现代医药卫生, 2017, 33(16):2428. doi: 10.3969/j.issn.1009-5519.2017.16.007
[7] DUCCINI K, DE SOUZA MVL, DELFIM R, et al.High serum thyrotropin concentrations within the reference range:A predictor of malignancy in nodular thyroid disease[J].Med Princ Pract, 2018, 27(3):272. doi: 10.1159/000488196
[8] HUANG H, RUSIECKI J, ZHAO N, et al.Thyroid-stimulating hormone, thyroid hormones, and risk of papillary thyroid cancer:A nested case-control study[J].Cancer Epidemiol Biomarkers Prev, 2017, 26(8):1209. doi: 10.1158/1055-9965.EPI-16-0845
[9] BASER H, TOPALOGLU O, TAM AA, et al.Higher TSH can be used as an additional risk factor in prediction of malignancy in euthyroid thyroid nodules evaluated by cytology based on Bethesda system[J].Endocrine, 2016, 53(2):520. doi: 10.1007/s12020-016-0919-4
[10] 刘长路, 吴岩, 毕立夫.甲状腺癌流行现状及危险因素的研究进展[J].中国地方病学杂志, 2012, 31(2):234. doi: 10.3760/cma.j.issn.1000-4955.2012.02.035